Orchestra BioMed Holdings, Inc. SEC filings OBIO
Orchestra BioMed Holdings, Inc. has 412 filings in SEC EDGAR's recent list, going back to Jun 22, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure, Other events
|
Oct 28, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Aug 4, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure, Other events
|
Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2025 | Feb 19, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 5, 2025 | Jan 30, 2025 |
| 8-K |
Current report
Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 30, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 11, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Other events
|
Mar 29, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 7, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 28, 2023 | Nov 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 19, 2023 | Sep 19, 2023 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Jul 13, 2023 | Jul 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 12, 2023 | Jul 12, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 8, 2023 | Jun 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 8, 2023 | Jun 8, 2023 |
| 8-K/A |
Amended current report
Results of operations
|
Mar 24, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jan 31, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jan 25, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Listing notice
|
Jan 24, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Other events
|
Jan 24, 2023 | Jan 20, 2023 |
| 8-K |
Current report
Change to shareholder rights
|
Dec 21, 2022 | Dec 15, 2022 |
| 8-K |
Current report
Change to shareholder rights
|
Nov 16, 2022 | Nov 15, 2022 |
| 8-K |
Current report
Change to shareholder rights
|
Oct 31, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Material agreement
|
Oct 21, 2022 | Oct 21, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jul 27, 2022 | Jul 26, 2022 |
| 8-K |
Current report
Other events
|
Jul 26, 2022 | Jul 22, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 5, 2022 | Jul 4, 2022 |
| 8-K |
Current report
Restatement
|
Feb 10, 2022 | Feb 4, 2022 |
| 8-K |
Current report
Other events
|
Aug 12, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Aug 7, 2020 | Aug 3, 2020 |
Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- OBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Hope, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1814114
- Former names
- Health Sciences Acquisitions Corp 2 (until Jan 26, 2023)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.